APLM - Apollomics Quarterly EPS earnings growth

Symbol and logo of brand Apollomics Inc. (APLM)

Apollomics, Inc. (APLM) is optimizing drug discovery through AI and robotic screening, confirming the resilience of its model. The quarterly EPS growth vector demonstrates this trend, where the parameter value reaches -1220.00. The strategy is based on licensing in China without mergers, while operational activities rely on strict ESG safety protocols and energy-efficient storage of biosamples.

Apollomics (APLM) - Quarterly EPS earnings growth from 02/21/2024 to 11/11/2026

Analytical breakdowns for Apollomics, Inc.

- market value and analyst target forecast:
Price Chart apollomicsinc.com|APLM - Fair Value Consensus
- market capitalization statistics:
Market Capitalization Apollomics Corp|APLM - Total Enterprise Value
- balance sheet net asset value indicators:
Book Value per Share Apollomics|APLM - Book Capitalization|Market Value to Book Value Ratio apollomicsinc.com|APLM - Total Asset Value of Company
- company liabilities and liquidity data:
Debt to Equity Apollomics, Inc.|APLM - Long-Term Liabilities to Capital|Short-Term Debt to Equity apollomicsinc.com|APLM - Company Debts|Debt to Book Capitalization Ratio Apollomics Corp|APLM - Company Long-Term Debt|Company Short-Term Debt Apollomics|Quick Liquidity apollomicsinc.com
- earnings and valuation multiples indicators:
APLM - Net Income|Projected Future Earnings Apollomics, Inc.|APLM - Business Payback Period|Forward P/E Multiple apollomicsinc.com|APLM - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Apollomics Corp|APLM - Operating income before deduction of amortization|Net earnings per share for the last 12 months Apollomics|APLM - Earnings per share for the trailing year|Quarterly EPS earnings growth apollomicsinc.com|APLM - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Apollomics, Inc.
Fundamental valuation:Apollomics, Inc.
Manufactured product of apollomicsinc.com

For Apollomics, Inc. (APLM), which is currently in the clinical trial stage without commercial revenue, financial stability is determined exclusively by the inflow of venture capital. This quarterly earnings per share chart reflects the dynamics of net income per security, allowing investors to assess the cash burn rate and market confidence in the potential of its molecule development.

Direct competitors

BeiGene (ONC) - Year-over-year earnings per share growth for the last twelve months|Halozyme Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|RVMD (RevMed) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Ascentage Pharma Corp AAPG|Quarterly EPS earnings growth CGON|Quarterly EPS earnings growth urogen.com (URGN)|Year-over-year earnings per share growth for the last twelve months Bicara Therapeutics BCAX|PSNL (Personalis Inc) - Year-over-year net earnings per share trend for the last twelve months|ERAS - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Delcath Corp|Y-mAbs Therapeutics (YMAB) - Year-over-year earnings per share growth for the last twelve months|AURA (aurabiosciences.com) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months Candel Therapeutics Inc.|Year-over-year earnings per share growth for the last twelve months ARAY|Year-over-year earnings per share growth for the last twelve months SELLAS Life Sciences (SLS)|ACTU - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Citius Oncology, Inc. CTOR|HURA - Year-over-year net earnings per share growth for the last 12 months|Protara Therapeutics, Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Fate Therapeutics Inc FATE|WHWK: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months TScan Therapeutics, Inc.|Year-over-year earnings per share growth for the last twelve months Champions Oncology Inc|XBiotech USA (XBIT) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CVM (CEL-SCI Corporation)|OSTX (OS Therapies Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth RADX (Radiopharm Theranostics)|Year-over-year net earnings per share change for the last twelve months Artiva Biotherapeutics Inc. (ARTV)|ANL - Year-over-year earnings per share growth for the last twelve months|VERU (verupharma.com) - Year-over-year earnings per share growth for the last 12 months|TPST: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Xilio Therapeutics|Year-over-year net earnings per share growth for the last 12 months RENB|Mural Bio (MURA) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth KAPA|Quarterly EPS earnings growth onkuretherapeutics.com (OKUR)|Year-over-year earnings per share growth for the last twelve months CytoMed Therapeutics Limited GDTC|CRIS (Curis Inc.) - Year-over-year net earnings per share trend for the last twelve months|THAR - Year-over-year earnings per share growth for the last twelve months|ADVB: Year-over-year earnings per share growth for the last twelve months|Genprex, Inc. (GNPX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Calidi Biotherapeutics, Inc.|SBFM (Sunshine Biopharma) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Xenetic Bio (XBIO)|Quarterly EPS earnings growth SLRX|Quarterly EPS earnings growth Kitov Pharma (PPBT)|Year-over-year earnings per share growth for the last twelve months American Oncology Network, Inc. AONC|BGNE: Year-over-year earnings per share growth for the last 12 months|Checkpoint Therapeutics, Inc. - Quarterly EPS earnings growth|Elevation Oncology Inc. (ELEV) - Year-over-year net earnings per share growth for the last 12 months|ICAD: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Ikena Oncology (IKNA)|Year-over-year earnings per share growth for the last twelve months Notable Labs, Ltd.|VIRX: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months MOR (MorphoSys)|NAYA (NAYA Biosciences Inc) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth AAPGV (Ascentage Pharma Group Ltd)